IP Library Patent Application 11263388
Patent Application
App. No. 11/263,388

Medicated breast pad

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/263,388
Abstract

A breast pad has a wax-like medicament, such as lanolin, disposed on an exposed surface of an inner surface of the pad in only a limited region, leaving other regions of the inner surface has a permeable region free of the medicament.

Claims (37)

1 . A breast pad comprising:

a core containing absorbent material; and

a liquid impermeable cover disposed on an outer side of the core;

wherein an inner surface of the core contains a wax-like medicament in a limited region thereof, such that the inner surface allows for absorption into the breast pad through a remaining medicament-free region of the inner surface of the core.

2 . The breast pad of claim 1 comprising between about 0.03 and 0.15 grams of medicament.

3 . (canceled)

4 . The breast pad of claim 1 wherein the medicament-free region comprises between about 30 and 50 percent of a total exposed surface area of the inner surface.

5 . (canceled)

6 . The breast pad of claim 1 wherein at least about 50 percent of a total exposed surface area of the inner surface is medicament-free.

7 . The breast pad of claim 1 wherein the limited region of medicament includes a central portion of the breast pad.

8 . The breast pad of claim 7 wherein the medicament is distributed uniformly within the central portion.

9 . The breast pad of claim 8 wherein the central portion is surrounded by the medicament-free region.

10 . The breast pad of claim 9 wherein the medicament-free region has a width of at least about 15 millimeters.

11 . The breast pad of claim 7 wherein the central portion includes both medicament and medicament-free areas.

12 . The breast pad of claim 1 wherein the medicament is in the form of a coating on the inner surface.

13 . The breast pad of claim 1 wherein the medicament is in the form of a dispersion on the inner surface.

14 - 17 . (canceled)

18 . The breast pad of claim 1 wherein the medicament comprises lanolin.

19 . A breast pad comprising:

an inner surface for contacting a mammary gland;

wherein the inner surface has a first region with a wax-like medicament and a second region that is free of wax-like medicaments; and

wherein the second region is permeable to fluids and permits absorption of mammary into the breast pad.

20 . The breast pad of claim 19 comprising between about 0.03 and 0.15 grams of medicament.

21 . (canceled)

22 . The breast pad of claim 19 wherein the region that is free of wax-like medicaments comprises between about 30 and 50 percent of a total exposed surface area of the inner surface.

23 . (canceled)

24 . The breast pad of claim 19 wherein at least about 50 percent of a total exposed surface area of the inner surface is the region that is free of wax-like medicaments.

25 . The breast pad of claim 19 wherein the medicament is in the form of a coating on the inner surface.

26 . The breast pad of claim 19 wherein the medicament is in the form of a dispersion on the inner surface.

27 - 29 . (canceled)

30 . The breast pad of claim 19 wherein the medicament comprises lanolin.

31 . A method of absorbing mammary fluids while soothing skin, the method comprising

providing a breast pad having an inner surface with a first region containing a wax-like medicament, and a second region that is free of wax-like medicaments and is permeable to permit absorption of mammary fluid into the pad; and

placing the breast pad on a human mammary gland, with the first region contacting at least a portion of an areola of the mammary gland and the permeable second region contacting the mammary gland for absorption of fluids.

32 . The method of claim 31 wherein the first region of the inner surface comprises between about 0.03 and 0.15 grams of medicament.

33 . The method of claim 31 wherein the first region of the inner surface is fluid impermeable.

34 . The method of claim 31 wherein the medicament comprises lanolin.